Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-19Clinical Trial Update: Vitamin D and Breast Cancer: Does Weight Make a Difference? [Phase 2]
Phase 2 trial evaluated whether vitamin D supplementation influences outcomes in breast cancer and whether patient weight affects the relati…
-
CLINICAL_TRIALS trial_result · 2019-04-18Clinical Trial Update: Pyrotinib in Combination With Nab-paclitaxel in Patients With HER2-positive Advanced Breast Cancer: an Exploratory Study [Phase 2]
Exploratory Phase 2 study evaluating pyrotinib in combination with nab-paclitaxel for HER2-positive advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Vinorelbine With Trastuzumab Emtansine in Pre-Treated HER2-Positive Metastatic Breast Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating vinorelbine with trastuzumab emtansine in pre-treated HER2-positive metastatic breast cancer has been …
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions [Phase 3]
Phase 3 trial update on zoledronic acid in metastatic breast cancer patients with non-symptomatic bone lesions; study terminated.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial of PANVAC-V and PANVAC-F vaccines with sargramostim in advanced cancers (adenocarcinoma, colorectal cancer; other listed con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-04-12Clinical Trial Update: Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer [Phase 2]
This entry reports results from a Phase 2 trial evaluating neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer. The result…
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC [Phase 2]
A Phase 2 trial evaluating pyrotinib in combination with trastuzumab and AI for first-line treatment of HER2-positive, hormone receptor-posi…
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients [Phase 4]
Phase 4 clinical trial update assessing efficacy and safety of neoadjuvant DC-T in breast cancer patients.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Contrast-Enhanced Digital Mammography (CEDM) for Identifying a Change in Management of Women With Newly Diagnosed Breast Cancer [NA]
Clinical trial update for contrast-enhanced digital mammography in women with newly diagnosed breast cancer; study terminated with results p…
-
CLINICAL_TRIALS trial_result · 2019-04-09Clinical Trial Update: Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer [Phase 3]
Phase 3 Clinical Study of UTD1 Injection combined with Capecitabine in advanced/metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC [Phase 2]
Phase 2 trial evaluating palbociclib with exemestane and GnRH versus capecitabine in premenopausal women with HR+ metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC) [Phase 2]
Phase 2 trial evaluating Kadcyla (trastuzumab emtansine) plus capecitabine in HER2-positive metastatic breast cancer or HER2-positive locall…
-
CLINICAL_TRIALS trial_result · 2019-04-08Clinical Trial Update: Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer [Phase 2]
Phase 2 trial update of Endostar in combination with chemotherapy for HER-2 negative advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-04-05Clinical Trial Update: Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole [Phase 3]
Phase 3 trial comparing fulvestrant plus anastrozole versus anastrozole alone in breast cancer reported terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Community Hospital Identification of High CV Risk Patients During Cancer Treatment [NA]
A terminated clinical trial at Wake Forest identified high cardiovascular risk patients during breast cancer treatment; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer [Phase 3]
Phase 3 trial update assessing participant satisfaction and safety with subcutaneously administered trastuzumab (Herceptin) in HER2-positive…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients [Phase 1, Phase 2]
Phase 1/2 trial assessing safety, tolerability, and efficacy of AZD5363 combined with paclitaxel in advanced/metastatic breast cancer (ER-po…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue [EARLY_Phase 1]
Early-phase trial evaluating whether conjugated linoleic acid (CLA) supplementation can modulate lipogenic pathways in breast cancer tissue;…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis [Phase 4]
Phase 4 open-label study in postmenopausal women with estrogen receptor–positive locally advanced or metastatic breast cancer evaluating eve…
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 dose-escalation trial of PF-06650808 in advanced solid tumors; terminated with posted results in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer [Phase 3]
A Phase 3 trial comparing dose-adjusted adjuvant FEC to standard FEC for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Partial Breast Irradiation With Chemotherapy [Phase 1, Phase 2]
Phase 1/2 trial evaluating partial breast irradiation with chemotherapy for breast cancer; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 3]
Phase 3 trial update for F-627 in women with breast cancer undergoing myelotoxic chemotherapy; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Cabergoline in Metastatic Breast Cancer [EARLY_Phase 1]
Early-phase trial updates the clinical trial of cabergoline in recurrent/metastatic breast cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064) [Phase 2]
Phase II trial evaluating ridaforolimus with exemestane versus ridaforolimus, dalotuzumab, and exemestane in breast cancer was completed wit…